Cite
HARVARD Citation
Park, W. et al. (n.d.). OP0167 A randomized, double-blind, phase 1 study demonstrates equivalence in pharmacokinetics, safety, and efficacy of CT-P13 and infliximab in patients with ankylosing spondylitis. Annals of the rheumatic diseases. p. 111. [Online].